Brain tissue grown in a laboratory by University of Queensland (UQ) researchers in Australia will be used to test a trea...
US-based Virginia Commonwealth University's Stravitz-Sanyal Institute for Liver Disease and Metabolic Health has announc...
Scientists at the University of Sydney, Australia with collaborators from Australia, South Korea and China. have devel...
Cancer is a leading cause of death worldwide, accounting for approximately one in six deaths, with metastatic ...
$5.7 million in research grants has been awarded to four projects aiming to foster research partnerships between institu...
Singapore-headquartered biopharmaceutical company Specialised Therapeutics Asia (ST) will partner with CTTQ-Akeso (Shang...
Chula Medicine researchers in Thailand have successfully published an article on the injection of patient's own platelet...
University of Otago researchers in New Zealand have discovered new ways to treat antibiotic-resistant strains of tubercu...
Tuberculosis (TB) patients can look forward to a much-shortened treatment period, compared to the current six-month trea...
JDRF Australia and funding partner The Leona M. and Harry B. Helmsley Charitable Trust have announced a combined additio...
Chulalongkorn University, Thailand, and Nagoya University, Japan, in their collaboration to develop an immunotherapy met...
A research team from South Korea-based Pohang University of Science and Technology (POSTECH) collaborated with researche...
Australia's University of Queensland (UQ) researchers have led a national study on the four main bacteria that cause sep...
Australia-based Griffith University’s world-first study into cell transplantation to repair injuries to the nervou...
A novel drug is showing promise for alleviating heart failure, a common condition associated with sleep apnoea and a red...
A new drug combination for men with advanced prostate cancer has shown sustained increase in survival rates. The result...
Victoria University of Wellington and University of Auckland, in New Zealand (NZ) have been named as co-hosts of a ...
In a boost to regenerative therapies for damaged hearts and eyes, Duke-NUS in Singapore has licensed two laminin-related...
